Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tharick A Pascoal

Showing results (1-10 of 226) with videos related to

Pageof 23
Sort By:
Science Translational Medicine|August 24, 2022
Comment on "Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases"Eduardo R Zimmer, Tharick A Pascoal, Pedro Rosa-Neto, et al.
Journal of Alzheimer'S Disease : JAD|March 6, 2018
Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and TreatmentSerge Gauthier, Kok Pin Ng, Tharick A Pascoal, et al.
Trends in Molecular Medicine|June 18, 2022
Staging of Alzheimer's disease: past, present, and future perspectivesJoseph Therriault, Eduardo R Zimmer, Andrea L Benedet, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 22, 2017
Characterizing biomarker features of cognitively normal individuals with ventriculomegalyXiaofeng Li, Maowen Ba, Kok Pin Ng, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative databaseMaowen Ba, Xiaofeng Li, Kok Pin Ng, et al.
Translational Neurodegeneration|October 13, 2018
Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's diseaseHua Zhang, Kok Pin Ng, Joseph Therriault, et al.
Alzheimer'S Research & Therapy|August 18, 2018
Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's diseaseHua Zhang, Joseph Therriault, Min Su Kang, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 15, 2024
Sex differences in Alzheimer's disease blood biomarkers in a Caribbean population of African ancestry: The Tobago Health StudyCaterina Rosano, Thomas K Karikari, Ryan Cvejkus, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 18, 2022
Subjective cognitive decline in Brazil: Prevalence and association with dementia modifiable risk factors in a population-based studyWyllians Vendramini Borelli, Eduardo R Zimmer, Andrei Bieger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisMarco De Bastiani, Christian Limberger, Débora Guerini de Souza, et al.
Pageof 23

Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
Science Translational Medicine|August 24, 2022
Comment on "Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases"Eduardo R Zimmer, Tharick A Pascoal, Pedro Rosa-Neto, et al.
Journal of Alzheimer'S Disease : JAD|March 6, 2018
Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and TreatmentSerge Gauthier, Kok Pin Ng, Tharick A Pascoal, et al.
Trends in Molecular Medicine|June 18, 2022
Staging of Alzheimer's disease: past, present, and future perspectivesJoseph Therriault, Eduardo R Zimmer, Andrea L Benedet, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 22, 2017
Characterizing biomarker features of cognitively normal individuals with ventriculomegalyXiaofeng Li, Maowen Ba, Kok Pin Ng, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative databaseMaowen Ba, Xiaofeng Li, Kok Pin Ng, et al.
Translational Neurodegeneration|October 13, 2018
Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's diseaseHua Zhang, Kok Pin Ng, Joseph Therriault, et al.
Alzheimer'S Research & Therapy|August 18, 2018
Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's diseaseHua Zhang, Joseph Therriault, Min Su Kang, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 15, 2024
Sex differences in Alzheimer's disease blood biomarkers in a Caribbean population of African ancestry: The Tobago Health StudyCaterina Rosano, Thomas K Karikari, Ryan Cvejkus, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 18, 2022
Subjective cognitive decline in Brazil: Prevalence and association with dementia modifiable risk factors in a population-based studyWyllians Vendramini Borelli, Eduardo R Zimmer, Andrei Bieger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisMarco De Bastiani, Christian Limberger, Débora Guerini de Souza, et al.
Pageof 23